F259-0692 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-2-(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamide

F259-0692 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-2-(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamide
F259-0692 Screening compound: N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-2-(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F259-0692
N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-2-(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F259-0692

Molecular Formula

C21H20N4O5S (C21 H20 N4 O5 S)

Compound Name

N-(2-acetamido-4-methoxy-1,3-benzothiazol-6-yl)-2-(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamide

IUPAC name

N-(2-acetamido-4-methoxy-13-benzothiazol-6-yl)-2-(2-methyl-3-oxo-34-dihydro-2H-14-benzoxazin-4-yl)acetamide

SMILES

CC1Oc(cccc2)c2N(CC(Nc(cc2OC)cc3c2nc(NC(C)=O)s3)=O)C1=O

InChI

InChI=1S/C21H20N4O5S/c1-11-20(28)25(14-6-4-5-7-15(14)30-11)10-18(27)23-13-8-16(29-3)19-17(9-13)31-21(24-19)22-12(2)26/h4-9,11H,10H2,1-3H3,(H,23,27)(H,22,24,26)/t11-/m1/s1

InChI Key

NKESXMYWJTYRMT-LLVKDONJSA-N

MDL Number (MFCD)

MFCD14946622

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.48

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.678

Distribution Coefficient, logD

2.677

Water Solubility, LogSw

-3.20

Polar Surface Area

87.645

Acid Dissociation Constant (pKa)

10.37

Base Dissociation Constant (pKb)

0.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.80

F259-0692 in Drug Discovery

Included in Screening Libraries

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F259-0692 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F259-0692?
Check Price and Availability of F259-0692, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F259-0692 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F259-0692
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F259-0692
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F259-0692 available by request